Your browser doesn't support javascript.
loading
Developmental pyrethroid exposure disrupts folate metabolism in mouse brain.
Curtis, Melissa A; Saferin, Nilanjana; Nguyen, Jennifer H; Imami, Ali S; Ryan, William G; Neifer, Kari L; Miller, Gary W; Burkett, James P.
Affiliation
  • Curtis MA; Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.
  • Saferin N; Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.
  • Nguyen JH; Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.
  • Imami AS; Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.
  • Ryan WG; Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.
  • Neifer KL; Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.
  • Miller GW; Department of Environmental Health, Emory Rollins School of Public Health, Atlanta, GA 30322.
  • Burkett JP; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032 (current).
bioRxiv ; 2024 Mar 26.
Article in En | MEDLINE | ID: mdl-37961675
ABSTRACT
Environmental and genetic risk factors, and their interactions, contribute significantly to the etiology of neurodevelopmental disorders (NDDs). Recent epidemiology studies have implicated pyrethroid pesticides as an environmental risk factor for autism and developmental delay. Our previous research showed that low-dose developmental exposure to the pyrethroid pesticide deltamethrin in mice caused male-biased changes in the brain and in NDD-relevant behaviors in adulthood. Here, we used a metabolomics approach to determine the broadest possible set of metabolic changes in the adult male mouse brain caused by low-dose pyrethroid exposure during development. Using a litter-based design, we exposed mouse dams during pregnancy and lactation to deltamethrin (3 mg/kg or vehicle every 3 days) at a concentration well below the EPA-determined benchmark dose used for regulatory guidance. We raised male offspring to adulthood and collected whole brain samples for untargeted high-resolution metabolomics analysis. Developmentally exposed mice had disruptions in 116 metabolites which clustered into pathways for folate biosynthesis, retinol metabolism, and tryptophan metabolism. As a cross-validation, we integrated metabolomics and transcriptomics data from the same samples, which confirmed previous findings of altered dopamine signaling. These results suggest that pyrethroid exposure during development leads to disruptions in folate metabolism in the adult brain, which may inform both prevention and therapeutic strategies.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2024 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2024 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA